Supplemental Tables.docx (68.05 kB)
Biologic initiation rates in systemic-naive psoriasis patients after first-line apremilast versus methotrexate use - Supplemental Tables.docx
dataset
posted on 2022-05-06, 09:13 authored by David Kaplan, Elaine Husni, Eunice Chang, Michael S. Broder, Caleb Paydar, Kata Bognar, Jessie Yan, Sven Richter, Pooja Desai, Ibrahim Khilfeh
Supplementary Table 1: Patient demographic characteristics and prescriber specialty
Supplementary Table 2: Baseline comorbidities
Supplementary Table 3: Baseline medication use
Supplementary Table 4: Baseline healthcare utilization, and costs
Supplementary Table 5: Number of index medication fills before biologic initiation during the 1-year follow-up period
Supplementary Table 6: First biologic medication used during the 1-year follow-up period among apremilast patients who initiated biologic
Supplementary Table 7: First biologic medication used during the 1-year follow-up period among methotrexate patients who initiated biologic
Supplementary Table 8: Biologic initiation adjusted results
